These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1560851)

  • 21. Multiple myeloma: a tailored therapy for elderly patients.
    Pileri A; Palumbo A; Boccadoro M
    Hematol Oncol; 1993; 11 Suppl 1():67-72. PubMed ID: 8486344
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy of multiple myeloma: present and future].
    Tura S
    G Clin Med; 1986 Dec; 67(5-6):261-4, 266-7. PubMed ID: 3301488
    [No Abstract]   [Full Text] [Related]  

  • 23. [Allogeneic bone marrow transplantation in multiple myeloma].
    Bandini G; Rosti G; Cavo M; Albertazzi L; Rizzi S; Motta MR; Gobbi M; Tassi C; Tazzari PL; Miggiano C
    Haematologica; 1989 Oct; 74(5 Suppl):463-72. PubMed ID: 2512229
    [No Abstract]   [Full Text] [Related]  

  • 24. [Status and trends in hematology].
    Stobbe H
    Z Arztl Fortbild (Jena); 1986; 80(18):741-4. PubMed ID: 3544527
    [No Abstract]   [Full Text] [Related]  

  • 25. VAMP followed by high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
    McElwain TJ; Gore ME; Meldrum M; Viner C; Judson IR; Malpas JS
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():109-12. PubMed ID: 2697419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multiple myeloma -- therapy].
    Jung W; Zettl F; Schroers R
    Dtsch Med Wochenschr; 2005 Feb; 130(6):283-6; quiz 287-90. PubMed ID: 15692903
    [No Abstract]   [Full Text] [Related]  

  • 27. Transplantation in multiple myeloma.
    Topolsky D; Biggs D
    Semin Oncol; 1995 Jun; 22(3):230-7. PubMed ID: 7777867
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of autologous stem cell transplantation in the management of multiple myeloma.
    Fermand JP; Brechignac S
    Pathol Biol (Paris); 1999 Feb; 47(2):199-202. PubMed ID: 10192889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose busulfan and cyclophosphamide are an effective conditioning regimen for allogeneic bone marrow transplantation in chemosensitive multiple myeloma.
    Cavo M; Bandini G; Benni M; Gozzetti A; Ronconi S; Rosti G; Zamagni E; Lemoli RM; Bonini A; Belardinelli A; Motta MR; Rizzi S; Tura S
    Bone Marrow Transplant; 1998 Jul; 22(1):27-32. PubMed ID: 9678792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early harvest and late transplantation as an effective therapeutic strategy in multiple myeloma.
    Gertz MA; Lacy MQ; Inwards DJ; Chen MG; Pineda AA; Gastineau DA; Greipp PR; Lust JA; Tefferi A; Witzig TE; Kyle RA; Litzow MR
    Bone Marrow Transplant; 1999 Feb; 23(3):221-6. PubMed ID: 10084252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
    Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
    Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Multiple myeloma].
    Almazov VA; Afanasév BV; Podoltseva ZI
    Klin Med (Mosk); 1993; 71(2):5-10. PubMed ID: 8046926
    [No Abstract]   [Full Text] [Related]  

  • 33. [High-dose melphalan in patients with multiple myeloma].
    Moreau P; Le Bonniec M; Harousseau JL
    Bull Cancer; 1999 Mar; 86(3):283-8. PubMed ID: 10210762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-dose chemotherapy in multiple myeloma.
    Atkins CD
    N Engl J Med; 1996 Dec; 335(24):1844; author reply 1845. PubMed ID: 8965895
    [No Abstract]   [Full Text] [Related]  

  • 35. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation for the treatment of multiple myeloma refractory to conventional chemotherapy].
    Shimokawa T; Kajiguchi T; Saito M; Kojima Y; Takeyama H
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):251-4. PubMed ID: 12610874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation.
    Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I
    Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myeloma.
    Harousseau JL; Attal M; Divine M; Milpied N; Marit G; Leblond V; Stoppa AM; Bourhis JH; Caillot D; Boasson M
    Bone Marrow Transplant; 1995 Jun; 15(6):963-9. PubMed ID: 7581098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dose-intensified therapy combined with autologous blood stem cell support in patients with multiple myeloma.
    Serke S; Kirsch A; Huhn D
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):29-32. PubMed ID: 7528448
    [No Abstract]   [Full Text] [Related]  

  • 39. [Progress in the treatment of multiple myeloma].
    Wada M; Mizoguchi H
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1079-88. PubMed ID: 9239160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Multiple myeloma: intensive chemotherapy and autotransplantation].
    Jubert-Leleu MC
    Soins; 1994 Oct; (589):34-6, 38. PubMed ID: 7676295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.